Complete Filing Data
PGIM Private Credit Fund reported Stockholders Equity of $204.67 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean PGIM Private Credit Fund did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income * | $21.8M | $15.1M | $9.6M | $42.0K |
| Other General And Administrative Expense | $373.0K | $115.0K | $146.0K | $20.0K |
| Interest Expense | $7.2M | $3.3M | $140.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $6.2M | $4.3M | $4.4M | $3.8M | $3.6M | $3.4M | $3.1M | $2.5M | $628.0K |
| Other General And Administrative Expense | $192.0K | $43.0K | $46.0K | $11.0K | $26.0K | $28.0K | $15.0K | $3.0K | $16.0K |
| Interest Expense | $1.6M | $1.8M | $1.7M | $992.0K | $449.0K | $251.0K | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity | $204.7M | $121.6M | $106.7M | $11.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.2M | |||
| Stockholders Equity Period Increase Decrease | $83.1M | $14.9M | $95.0M | $11.7M |
| Debt And Equity Securities Realized Gain Loss | -$979.0K | $14.0K | $2.0K | $0.00 |
| Debt Securities Realized Gain Loss | -$895.0K | -$138.0K | $46.0K | $0.00 |
| Retained Earnings Accumulated Deficit | $85.0K | $42.0K | ||
| Liabilities | $13.7M | $92.0K | ||
| Investments Owned And Cash Equivalent Percent Of Net Assets | $1.08 | $1.00 | ||
| Investments Owned And Cash Equivalent Fair Value Disclosure | $115.1M | $11.7M | ||
| Investments Foreign Currency At Fair Value | $199.0K | $0.00 | ||
| Interest Receivable | $584.0K | $43.0K | ||
| Debt And Equity Securities Unrealized Gain Loss | -$471.0K | $431.0K | $0.00 | |
| Custodian And Accounting Fees Payable | $74.0K | $22.0K | ||
| Common Stock Value | $4.0K | $0.00 | ||
| Cash And Cash Equivalents At Carrying Value | $16.1M | $3.2M | ||
| Assets | $120.4M | $11.8M | ||
| Accrued Professional Fees Current And Noncurrent | $962.0K | $50.0K | ||
| Accounts Payable And Accrued Liabilities Current And Noncurrent | $45.0K | $20.0K | ||
| Unrealized Gain Loss On Investments | -$471.0K | $431.0K | $0.00 | |
| Accretion Amortization Of Discounts And Premiums Investments | $803.0K | $519.0K | $2.0K | |
| Receivable Investment Sale | $21.0K | $0.00 | ||
| Amortization Of Deferred Charges | $241.0K | $41.0K | $0.00 | |
| Transfer Agents Fees Payable | $14.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $182.8M | $163.4M | $146.1M | $117.2M | $113.6M | $109.6M | $115.4M | $112.3M | $109.6M | $66.8M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $5.3M | $5.8M | $15.3M | $5.1M | $12.3M | $4.0M | $3.3M | $16.3M | $30.6M | $37.2M | $26.1M | ||
| Stockholders Equity Period Increase Decrease | $19.3M | $17.3M | $24.5M | $3.5M | $4.0M | $2.9M | $3.2M | $45.5M | $55.0M | ||||
| Debt And Equity Securities Realized Gain Loss | $13.0K | -$1.0M | $4.0K | $8.0K | $8.0K | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Debt Securities Realized Gain Loss | $11.0K | -$953.0K | $400.0K | $27.0K | $77.0K | -$135.0K | $57.0K | -$13.0K | $12.0K | ||||
| Retained Earnings Accumulated Deficit | $796.0K | $430.0K | $1.4M | $1.3M | $1.4M | $1.0M | $504.0K | $6.3M | $3.2M | $670.0K | |||
| Liabilities | $87.5M | $100.0M | $98.8M | $96.2M | $71.2M | $22.8M | $9.1M | $514.0K | $298.0K | $7.0M | |||
| Investments Owned And Cash Equivalent Percent Of Net Assets | $1.43 | $1.56 | $1.55 | $1.72 | $1.54 | $1.14 | $1.03 | $0.97 | $0.98 | $1.08 | |||
| Investments Owned And Cash Equivalent Fair Value Disclosure | $260.7M | $254.5M | $227.0M | $209.2M | $180.9M | $130.0M | $112.9M | $112.3M | $110.5M | $72.2M | |||
| Investments Foreign Currency At Fair Value | $1.8M | $2.0M | $1.7M | $1.4M | $1.3M | $756.0K | $816.0K | $65.0K | $73.0K | $916.0K | |||
| Interest Receivable | $2.1M | $1.5M | $1.3M | $1.1M | $1.7M | $1.1M | $841.0K | $515.0K | $622.0K | $390.0K | |||
| Debt And Equity Securities Unrealized Gain Loss | $710.0K | $896.0K | $160.0K | -$245.0K | $53.0K | $34.0K | $79.0K | ||||||
| Custodian And Accounting Fees Payable | $129.0K | $143.0K | $77.0K | $172.0K | $244.0K | $158.0K | $74.0K | $160.0K | $112.0K | $67.0K | |||
| Common Stock Value | $7.0K | $7.0K | $6.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $3.0K | |||
| Cash And Cash Equivalents At Carrying Value | $3.5M | $3.8M | $13.7M | $3.7M | $11.0M | $3.2M | $2.5M | $30.5M | $37.2M | $25.2M | |||
| Assets | $270.3M | $263.5M | $244.9M | $217.8M | $188.4M | $136.4M | $118.6M | $116.0M | $112.6M | $73.7M | |||
| Accrued Professional Fees Current And Noncurrent | $146.0K | $63.0K | $96.0K | $200.0K | $12.0K | $207.0K | $837.0K | $103.0K | $113.0K | $75.0K | |||
| Accounts Payable And Accrued Liabilities Current And Noncurrent | $21.0K | $28.0K | $27.0K | $58.0K | $147.0K | $61.0K | $74.0K | $9.0K | $7.0K | $36.0K | |||
| Unrealized Gain Loss On Investments | $710.0K | -$245.0K | $79.0K | ||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $385.0K | $166.0K | $28.0K | ||||||||||
| Receivable Investment Sale | $310.0K | $155.0K | $34.0K | $33.0K | $203.0K | $180.0K | $0.00 | $18.0K | $79.0K | ||||
| Amortization Of Deferred Charges | $65.0K | $60.0K | $60.0K | $0.00 | $0.00 | ||||||||
| Transfer Agents Fees Payable | $26.0K | $0.00 | $19.0K | $16.0K | $0.00 | $0.00 | $5.0K | $16.0K | $27.0K | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Proceeds From Issuance Of Common Stock | $1.2M | $97.4M | $11.7M |
| Proceeds From Disposition Of Investment Operating Activity | $9.5M | $7.3M | $0.00 |
| Payments For Purchase Of Investment Operating Activity | $117.3M | $98.9M | $8.5M |
| Net Cash Provided By Used In Operating Activities | -$94.3M | -$83.2M | -$8.5M |
| Net Cash Provided By Used In Financing Activities | $83.2M | $96.2M | $11.7M |
| Increase Decrease In Due From Management Current | -$873.0K | $1.2M | $89.0K |
| Increase Decrease In Custodian And Accounting Fees Payable | $98.0K | $52.0K | $22.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $13.0K | $25.0K | $20.0K |
| Increase Decrease In Accrued Interest Receivable Net | $480.0K | $541.0K | $43.0K |
| Increase Decrease In Transfer Agents Fees Payable | $2.0K | $14.0K | $0.00 |
| Increase Decrease In Receivable For Investment Sold | $12.0K | $21.0K | $0.00 |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$36.0K | $2.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|
| Proceeds From Issuance Of Common Stock | $20.3M | $500.0K | $54.4M |
| Proceeds From Disposition Of Investment Operating Activity | $12.5M | $2.9M | $237.0K |
| Payments For Purchase Of Investment Operating Activity | $29.0M | $14.4M | $32.5M |
| Net Cash Provided By Used In Operating Activities | -$12.4M | -$8.0M | -$31.5M |
| Net Cash Provided By Used In Financing Activities | $22.5M | -$4.9M | $54.4M |
| Increase Decrease In Due From Management Current | -$259.0K | -$577.0K | $78.0K |
| Increase Decrease In Custodian And Accounting Fees Payable | -$95.0K | $0.00 | $45.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$31.0K | $29.0K | $60.0K |
| Increase Decrease In Accrued Interest Receivable Net | $250.0K | $257.0K | $347.0K |
| Increase Decrease In Transfer Agents Fees Payable | $3.0K | -$9.0K | $0.00 |
| Increase Decrease In Receivable For Investment Sold | $1.0K | -$21.0K | $79.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $65.0K | -$3.0K | -$5.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 |
|---|---|---|
| Common Stock Shares Outstanding | 4.3M | 468.1K |
| Common Stock Shares Issued | 4.3M | 468.1K |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Shares Outstanding | 7.4M | 6.6M | 5.9M | 4.9M | 4.7M | 4.6M | 4.4M | 4.3M | 4.3M | 2.6M |
| Common Stock Shares Issued | 7.4M | 6.6M | 5.9M | 4.9M | 4.7M | 4.6M | 4.4M | 4.3M | 4.3M | 2.6M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Unrealized Gain Loss On Derivatives | -$2.7M | $1.3M | -$282.0K | $0.00 |
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | $1.9M | $774.0K | $151.0K | $0.00 |
| Trustees Fees | $202.0K | $206.0K | $176.0K | $0.00 |
| Realized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | -$895.0K | -$138.0K | $46.0K | $0.00 |
| Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | $977.0K | $636.0K | $197.0K | $0.00 |
| Professional Fees | $2.7M | $2.3M | $2.2M | $50.0K |
| Net Investment Income | $20.8M | $14.4M | $9.4M | $42.0K |
| Investment Income Investment Expense | $15.5M | $9.4M | $4.4M | $92.0K |
| Investment Company Increase Decrease From Share Transaction | $83.3M | $13.8M | $98.4M | $11.7M |
| Investment Company Expense Reimbursement | $3.5M | $2.9M | $2.7M | $89.0K |
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $8.0M | $3.8M | $560.0K | $3.0K |
| Gross Investment Income Operating | $28.8M | $18.2M | $10.0M | $45.0K |
| Foreign Currency Transaction Gain Loss Realized | $74.0K | -$11.0K | -$17.0K | $0.00 |
| Custodian And Accounting Fees | $321.0K | $337.0K | $200.0K | $22.0K |
| Transfer Agents Fees And Expenses | $336.0K | $223.0K | $161.0K | $0.00 |
| Pricing Fees | $85.0K | $50.0K | $105.0K | $0.00 |
| Investment Company Shareholder Service Fee Expense | $301.0K | $181.0K | $105.0K | $0.00 |
| Incentive Fee Expense | $1.8M | $1.2M | $608.0K | $0.00 |
| Gain Loss On Sale Of Derivatives | $10.0K | -$141.0K | $61.0K | $0.00 |
| Foreign Currency Transaction Gain Loss Unrealized After Tax | $37.0K | -$36.0K | $2.0K | $0.00 |
| Management Fee Expense | $2.1M | $1.4M | $485.0K | $0.00 |
| Interest Income Operating | $27.3M | $17.7M | $8.6M | $45.0K |
| Investment Company Incentive Fees Waived | $1.3M | $608.0K | $0.00 | |
| Expense Related To Distribution Or Servicing And Underwriting Fees | $0.00 | $0.00 | $0.00 | $0.00 |
| Management Fees Waived | $1.4M | $485.0K | $0.00 | |
| Investment Company Distribution Ordinary Income | $22.0M | $14.0M | $8.4M | $0.00 |
| Fee Income | $730.0K | $243.0K | $108.0K | $0.00 |
| Capital Gains Incentive Fees | $122.0K | $104.0K | $0.00 | $0.00 |
| Blue Sky Fees Incurred | $0.00 | $90.0K | $0.00 | $0.00 |
| Investment Owned At Fair Value | $101.0M | $8.5M | ||
| Investment Owned At Cost | $100.6M | $8.5M | ||
| Additional Paid In Capital | $106.6M | $11.7M | ||
| Noninterest Expense Transfer Agent And Custodian Fees | $500.0K | $500.0K | $500.0K | |
| Change In Unrealized Appreciation And Depreciation | $774.0K | $151.0K | $0.00 | |
| Realized Investment Gains Losses | $14.0K | $2.0K | $0.00 | |
| Unrealized Depreciation On Foreign Currency Forward Contracts | $282.0K | $0.00 | ||
| Unfunded Loan Commitment | $13.5M | $1.7M | ||
| Total Commitment Fair Value | -$263.0K | -$26.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Unrealized Gain Loss On Derivatives | $304.0K | -$1.8M | -$1.2M | -$979.0K | $41.0K | $457.0K | $15.0K | $20.0K | -$11.0K | |
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | $1.0M | $227.0K | -$435.0K | -$54.0K | $204.0K | $209.0K | $67.0K | $59.0K | $63.0K | |
| Trustees Fees | $52.0K | $51.0K | $51.0K | $54.0K | $52.0K | $47.0K | $204.0K | $44.0K | $44.0K | |
| Realized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | $11.0K | -$953.0K | $400.0K | $27.0K | $77.0K | -$135.0K | $57.0K | -$13.0K | $12.0K | |
| Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | $1.0M | -$726.0K | -$35.0K | -$27.0K | $281.0K | $74.0K | $124.0K | $46.0K | $75.0K | |
| Professional Fees | $1.0M | $358.0K | $315.0K | $373.0K | $821.0K | $575.0K | $770.0K | $201.0K | $25.0K | |
| Net Investment Income | $5.2M | $5.0M | $4.4M | $3.9M | $3.3M | $3.3M | $3.0M | $2.5M | $553.0K | |
| Investment Income Investment Expense | $4.2M | $3.3M | $3.1M | $2.3M | $2.1M | $1.7M | $1.5M | $595.0K | $130.0K | |
| Investment Company Increase Decrease From Share Transaction | $19.0M | $18.3M | $24.4M | $3.2M | $3.5M | $2.5M | $45.0K | $43.0M | $54.4M | |
| Investment Company Expense Reimbursement | $1.3M | $474.0K | $413.0K | $511.0K | $953.0K | $795.0K | $1.0M | $285.0K | $78.0K | |
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $1.9M | $1.9M | $1.9M | $1.1M | $589.0K | $344.0K | $142.0K | $125.0K | $52.0K | |
| Gross Investment Income Operating | $7.1M | $7.0M | $6.3M | $5.0M | $3.9M | $3.6M | $3.1M | $2.6M | $605.0K | |
| Foreign Currency Transaction Gain Loss Realized | $46.0K | $106.0K | -$104.0K | $3.0K | -$4.0K | $9.0K | -$1.0K | -$5.0K | $12.0K | |
| Custodian And Accounting Fees | $66.0K | $66.0K | $65.0K | $87.0K | $84.0K | $67.0K | $48.0K | $45.0K | $45.0K | |
| Transfer Agents Fees And Expenses | $113.0K | $54.0K | $52.0K | $69.0K | $41.0K | $28.0K | $54.0K | $78.0K | $0.00 | |
| Pricing Fees | $12.0K | $13.0K | $12.0K | $27.0K | $25.0K | $27.0K | $39.0K | $27.0K | $0.00 | |
| Investment Company Shareholder Service Fee Expense | $95.0K | $78.0K | $35.0K | $34.0K | $44.0K | $26.0K | $41.0K | $12.0K | $0.00 | |
| Incentive Fee Expense | $336.0K | $507.0K | $448.0K | $254.0K | $218.0K | $220.0K | $212.0K | $185.0K | $0.00 | |
| Gain Loss On Sale Of Derivatives | -$48.0K | -$47.0K | $500.0K | $16.0K | $73.0K | -$144.0K | $58.0K | -$8.0K | $0.00 | |
| Foreign Currency Transaction Gain Loss Unrealized After Tax | -$47.0K | $3.0K | $65.0K | $29.0K | $3.0K | -$3.0K | -$1.0K | $5.0K | -$5.0K | |
| Management Fee Expense | $550.0K | $491.0K | $406.0K | $364.0K | $349.0K | $336.0K | $118.0K | $0.00 | $0.00 | |
| Interest Income Operating | $6.7M | $6.6M | $6.1M | $4.9M | $3.8M | $3.5M | $2.6M | $2.1M | $565.0K | |
| Investment Company Incentive Fees Waived | $463.0K | $417.0K | $443.0K | $251.0K | $253.0K | $254.0K | $212.0K | $185.0K | $0.00 | |
| Expense Related To Distribution Or Servicing And Underwriting Fees | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Management Fees Waived | $550.0K | $491.0K | $406.0K | $364.0K | $349.0K | $336.0K | $118.0K | $0.00 | $0.00 | |
| Investment Company Distribution Ordinary Income | $5.9M | $5.3M | $4.2M | $3.5M | $3.1M | $3.0M | $0.00 | $0.00 | $0.00 | |
| Fee Income | $57.0K | $159.0K | $106.0K | $68.0K | $50.0K | $59.0K | $50.0K | $0.00 | $0.00 | |
| Capital Gains Incentive Fees | $127.0K | -$90.0K | -$5.0K | -$3.0K | $35.0K | $34.0K | $0.00 | $0.00 | $0.00 | |
| Blue Sky Fees Incurred | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $90.0K | $0.00 | $0.00 | $0.00 | |
| Investment Owned At Fair Value | $260.7M | $254.4M | $226.8M | $209.2M | $172.9M | $129.7M | $112.5M | $83.9M | $74.5M | $47.0M |
| Investment Owned At Cost | $257.3M | $251.7M | $226.1M | $209.3M | $171.6M | $129.3M | $112.3M | $83.8M | $74.4M | $46.9M |
| Additional Paid In Capital | $182.0M | $163.0M | $144.7M | $120.3M | $115.8M | $112.6M | $109.1M | $109.1M | $109.1M | $66.1M |
| Noninterest Expense Transfer Agent And Custodian Fees | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $6.0K | |||
| Change In Unrealized Appreciation And Depreciation | -$435.0K | -$54.0K | $204.0K | $209.0K | $67.0K | $59.0K | $63.0K | |||
| Realized Investment Gains Losses | $4.0K | $0.00 | $0.00 | |||||||
| Unrealized Depreciation On Foreign Currency Forward Contracts | $1.7M | $2.0M | $376.0K | $7.0K | $763.0K | $27.0K | $3.0K | $11.0K | ||
| Unfunded Loan Commitment | $28.0M | $25.6M | $21.7M | $13.8M | $13.1M | $7.4M | $6.1M | $2.5M | ||
| Total Commitment Fair Value | -$379.0K | -$328.0K | -$316.0K | -$218.0K | -$258.0K | -$147.0K | -$140.0K | -$68.0K |
Most recent annual filing with the SEC: March 18, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.